Clinical Trials

22 enrolled

Lymphoma, Non-Hodgkin

NCT05487651 2023-05-18

ANCHOR2

LymphoidOther hematologic neoplasmSarcoma

36 enrolled

Lymphoma, Non-Hodgkin, Recurrence, Leukemia, B-Cell, Lymphoma, B-Cell, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Dendritic Cell Sarcoma, Interdigitating

NCT04356846 2023-05-01

A Phase I Study of LP-108 in Patients With Relapsed or Refractory B-cell Lymphoma

74 enrolled

Lymphoma, Non-Hodgkin, Leukemia, Lymphocytic, Chronic, B-Cell

NCT03688451 2023-03-29

Intrathecal Rituximab With Standard Intrathecal Prophylaxis to Prevent CNS Relapse for CD 20+ Non Hodgkin Lymphoma

20 enrolled

Lymphoma, Non-Hodgkin

NCT01811368 2022-11-30

Zevalin Before Stem Cell Transplant in Treating Patients With Non-Hodgkin Lymphoma

20 enrolled

Lymphoma, Non-Hodgkin

NCT05557903 2022-09-28

Phase Ⅰ Clinical Study of Anti-CD52 Monoclonal Antibody in NHL and T-PLL

71 enrolled

Lymphoma, Non-Hodgkin, Recurrence, Lymphoma, T-Cell

NCT05477667 2022-07-28

Study of Let-7a and miRNA-124 in Cases of Non-Hodgkin's Lymphoma and Acute Leukemia

Phase NA Unknown

Lymphoma, Non-Hodgkin

NCT05410041 2022-06-08

Anti-CD19 CAR-Engineered NK Cells in the Treatment of Relapsed/Refractory B-cell Malignancies

15 enrolled

Lymphoma, Non-Hodgkin, Leukemia, Lymphocytic, Chronic, B-Cell, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT03958916 2022-05-09

Prospective Multicenters Clinical Cohort Study of Stratified Treatment of Chinese Children With BL/DLBCL

500 enrolled

Lymphoma, Non-Hodgkin, Neoplasms

NCT03971305 2022-05-09

A Prospective Multicenters Clinical Cohort Study of Stratified Treatment of Chinese Children With Systemic ALK(+) ALCL

300 enrolled

Lymphoma, Non-Hodgkin, Neoplasms

NCT03971318 2022-05-09

A Prospective Multicenters Clinical Cohort Study of Stratified Treatment of Chinese Children With LBL

300 enrolled

Lymphoma, Non-Hodgkin, Neoplasms, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT05349266 2022-04-27

Assessment of Safety and Efficacy of ThisCART19A in Adult Patients With B-NHL After Failure of Autologous Chimeric Antigen Receptor T- Cell(CAR-T) Therapy

16 enrolled

Lymphoma, Non-Hodgkin

NCT05320640 2022-04-11

Study of Chidamide, Decitabine and Immune Checkpoint Inhibitors in R/R NHL and Advanced Solid Tumors

Phase 1/2 Unknown

Lymphoma, Non-Hodgkin

NCT04514393 2022-04-07

Ibrutinib With Methotrexate and Temozolomide for Patients With Newly Diagnosed Primary CNS Lymphoma

33 enrolled

Lymphoma, Non-Hodgkin

NCT05191225 2022-03-31

Ultrafast Truxima Infusion in Non-Hodgkin's Lymphoma: Txagorapid Study

Phase 4 Unknown

48 enrolled

Lymphoma, Non-Hodgkin

NCT05200312 2022-03-11

ZR2-CHOP

36 enrolled

Lymphoma, Non-Hodgkin, Lymphoma, Large B-Cell, Diffuse

NCT05206071 2022-01-25

Clinical Study of SL19+22 CAR-T Cells for Relapsed or Refractory Non-Hodgkin Lymphoma

Phase NA Unknown

LymphoidMyeloidOther hematologic neoplasm

Lymphoma, Non-Hodgkin

NCT05066958 2021-10-04

Ex-vivo Primed Memory Donor Lymphocyte Infusion to Boost Anti-viral Immunity After T-cell Depleted HSCT

Phase 1/2 Unknown

20 enrolled

Lymphoma, Non-Hodgkin, Myelodysplastic Syndromes, Virus Diseases, Leukemia, Myeloid, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT05021770 2021-08-26

Orelabrutinib in Combination With Thiotepa in Refractory and Relapsed Primary CNS Lymphoma

Phase 1/2 Unknown

29 enrolled

Lymphoma, Non-Hodgkin

NCT00003337 2021-08-16

Radiolabeled Monoclonal Antibody in the Detection and Staging of Patients With Non-Hodgkin's Lymphoma

Phase 3 Unknown

Burkitt Lymphoma, Lymphoma, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, Large-Cell, Immunoblastic, Lymphoma, Large B-Cell, Diffuse, Lymphoma, B-Cell, Marginal Zone, Lymphoma, Mantle-Cell, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT00003338 2021-08-16

Monoclonal Antibodies in Detecting Residual Disease in Patients Who Have Been Treated for Non-Hodgkin's Lymphoma

Phase 2/3 Unknown

60 enrolled

Burkitt Lymphoma, Lymphoma, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, Large-Cell, Immunoblastic, Lymphoma, Large B-Cell, Diffuse, Lymphoma, B-Cell, Marginal Zone, Lymphoma, Mantle-Cell, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT04539444 2021-08-02

A Study of CD19/22 CART Cells Combined With PD-1 Inhibitor in Relapsed/Refractory B-cell Lymphoma

10 enrolled

Lymphoma, Non-Hodgkin, Recurrence

NCT00317096 2021-05-07

FCM Versus R-FCM Followed by R-Maintenance or Observation Only

Phase 3 Unknown

319 enrolled

Lymphoma, Follicular, Lymphoma, Non-Hodgkin

NCT04796675 2021-04-08

Cord Blood Derived Anti-CD19 CAR-Engineered NK Cells for B Lymphoid Malignancies

27 enrolled

Lymphoma, Non-Hodgkin, Leukemia, Lymphocytic, Chronic, B-Cell, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT03595813 2021-03-29

IMMUNO-SUP

Phase NA Unknown

135 enrolled

GenitourinaryLymphoid

Lymphoma, Non-Hodgkin, Urologic Neoplasms

NCT03000192 2021-03-17

HORIZONS: Understanding the Impact of Cancer Diagnosis and Treatment on Everyday Life